Your browser doesn't support javascript.
loading
RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Singhal, Sharad S; Nagaprashantha, Lokesh; Singhal, Preeti; Singhal, Sulabh; Singhal, Jyotsana; Awasthi, Sanjay; Horne, David.
Affiliation
  • Singhal SS; Department of Molecular Medicine, Comprehensive Cancer Center and National Medical Center, Beckman Research Institute of City of Hope, Duarte, California, 91010, USA. ssinghal@coh.org.
  • Nagaprashantha L; Department of Molecular Medicine, Comprehensive Cancer Center and National Medical Center, Beckman Research Institute of City of Hope, Duarte, California, 91010, USA.
  • Singhal P; University of Texas Health, San Antonio, Texas, 78229, USA.
  • Singhal S; University of California at San Diego, La Jolla, California, 92092, USA.
  • Singhal J; Department of Molecular Medicine, Comprehensive Cancer Center and National Medical Center, Beckman Research Institute of City of Hope, Duarte, California, 91010, USA.
  • Awasthi S; Texas Tech University Health Sciences Center, Lubbock, Texas, 79430, USA.
  • Horne D; Department of Molecular Medicine, Comprehensive Cancer Center and National Medical Center, Beckman Research Institute of City of Hope, Duarte, California, 91010, USA.
Pharm Res ; 34(8): 1673-1682, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28386633

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / ATP-Binding Cassette Transporters / GTPase-Activating Proteins / Neuroblastoma / Antineoplastic Agents Limits: Animals / Child / Humans Language: En Journal: Pharm Res Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / ATP-Binding Cassette Transporters / GTPase-Activating Proteins / Neuroblastoma / Antineoplastic Agents Limits: Animals / Child / Humans Language: En Journal: Pharm Res Year: 2017 Type: Article Affiliation country: United States